Literature DB >> 18959466

Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells.

Raymond P Baumann1, Philip G Penketh, Helen A Seow, Krishnamurthy Shyam, Alan C Sartorelli.   

Abstract

The poor and aberrant vascularization of solid tumors makes them susceptible to localized areas of oxygen deficiency that can be considered sites of tumor vulnerability to prodrugs that are preferentially activated to cytotoxic species under conditions of low oxygenation. To readily facilitate the selection of agents targeted to oxygen-deficient cells in solid tumors, we have developed a simple and convenient two-enzyme system to generate oxygen deficiency in cell cultures. Glucose oxidase is employed to deplete oxygen from the medium by selectively oxidizing glucose and reducing molecular oxygen to hydrogen peroxide; an excess of catalase is also used to scavenge the peroxide molecules. Rapid and sustained depletion of oxygen occurs in medium or buffer, even in the presence of oxygen at the liquid/air interface. Studies using CHO/AA8 Chinese hamster cells, EMT6 murine mammary carcinoma cells, and U251 human glioma cells indicate that this system generates an oxygen deficiency that produces activation of the hypoxia-targeted prodrug KS119. This method of generating oxygen deficiency in cell culture is inexpensive, does not require cumbersome equipment, permits longer incubation times to be used without the loss of sample volume, and should be adaptable for high-throughput screening in 96-well plates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18959466      PMCID: PMC2667281          DOI: 10.1667/RR1431.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  20 in total

1.  KINETICS AND MECHANISM OF ACTION OF GLUCOSE OXIDASE.

Authors:  Q H GIBSON; B E SWOBODA; V MASSEY
Journal:  J Biol Chem       Date:  1964-11       Impact factor: 5.157

2.  1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.

Authors:  Helen A Seow; Philip G Penketh; Krishnamurthy Shyam; Sara Rockwell; Alan C Sartorelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

3.  Liver catalase. I. A manometric determination of catalase activity.

Authors:  R E GREENFIELD; V E PRICE
Journal:  J Biol Chem       Date:  1954-07       Impact factor: 5.157

4.  Biochemistry without oxygen.

Authors:  S W Englander; D B Calhoun; J J Englander
Journal:  Anal Biochem       Date:  1987-03       Impact factor: 3.365

5.  Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma.

Authors:  P W Vaupel; S Frinak; H I Bicher
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

6.  Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines.

Authors:  K Shyam; P G Penketh; M Shapiro; M F Belcourt; R H Loomis; S Rockwell; A C Sartorelli
Journal:  J Med Chem       Date:  1999-03-11       Impact factor: 7.446

7.  The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells.

Authors:  M F Belcourt; W F Hodnick; S Rockwell; A C Sartorelli
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

8.  Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.

Authors:  K Shyam; P G Penketh; R H Loomis; W C Rose; A C Sartorelli
Journal:  J Med Chem       Date:  1996-02-02       Impact factor: 7.446

Review 9.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

10.  Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents.

Authors:  K Shyam; P G Penketh; A A Divo; R H Loomis; C L Patton; A C Sartorelli
Journal:  J Med Chem       Date:  1990-08       Impact factor: 7.446

View more
  25 in total

1.  4-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.

Authors:  Rui Zhu; Mao-Chin Liu; Mei-Zhen Luo; Philip G Penketh; Raymond P Baumann; Krishnamurthy Shyam; Alan C Sartorelli
Journal:  J Med Chem       Date:  2011-10-17       Impact factor: 7.446

2.  Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity.

Authors:  Yun Wang; Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Mol Cancer Ther       Date:  2010-05-25       Impact factor: 6.261

3.  Luminescent Nanosensors for Ratiometric Monitoring of Three-Dimensional Oxygen Gradients in Laboratory and Clinical Pseudomonas aeruginosa Biofilms.

Authors:  Megan P Jewell; Anne A Galyean; J Kirk Harris; Edith T Zemanick; Kevin J Cash
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

4.  A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX.

Authors:  Xiang Li; Subin M George; Lawrence Vernetti; Albert H Gough; D Lansing Taylor
Journal:  Lab Chip       Date:  2018-08-21       Impact factor: 6.799

5.  Activation of voltage-dependent K+ channels strongly limits hypoxia-induced elevation of [Ca2+ ]i in rat carotid body glomus cells.

Authors:  Jiaju Wang; Donghee Kim
Journal:  J Physiol       Date:  2017-12-28       Impact factor: 5.182

6.  Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.

Authors:  Rui Zhu; Helen A Seow; Raymond P Baumann; Kimiko Ishiguro; Philip G Penketh; Krishnamurthy Shyam; Alan C Sartorelli
Journal:  Bioorg Med Chem Lett       Date:  2012-08-10       Impact factor: 2.823

7.  Ca2+ oscillations in rat carotid body type 1 cells in normoxia and hypoxia.

Authors:  Donghee Kim; James O Hogan; Carl White
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

8.  Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.

Authors:  Raymond P Baumann; Philip G Penketh; Kimiko Ishiguro; Krishnamurthy Shyam; Yong L Zhu; Alan C Sartorelli
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

9.  Hypoxia-selective O6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O6-benzylguanine.

Authors:  Rui Zhu; Raymond P Baumann; Philip G Penketh; Krishnamurthy Shyam; Alan C Sartorelli
Journal:  J Med Chem       Date:  2013-01-23       Impact factor: 7.446

10.  A simple and inexpensive method to control oxygen concentrations within physiological and neoplastic ranges.

Authors:  P G Penketh; K Shyam; R P Baumann; E S Ratner; A C Sartorelli
Journal:  Anal Biochem       Date:  2015-09-08       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.